"YaoXie one" the product since has very rapid development momentum listed, so far, has developed the hundreds of YaoXie tested one of new products. But, in the country, this kind of product is still pay for patients and the prices at expensive, limiting its market growth space.
The filling type syringe
Its representatives namely for insulin pen, China wrist blood pressure monitor foreign new development of the new products and filling type syringe needle EPO, HGH needle (people growth hormone needle), alpha interferon needle, anesthetic needles and so on the disposable injection products.China forehead thermometer Because of its low prices and easy to use,China electronic thermometer manufacturer this kind of products sell very well in Europe and America market, especially in foreign years sales needle EPO as high as tens of millions of pieces.
From 2008 till now, the filling syringes market of the comprehensive annual growth rate can amount to 8.7%, various global filling type of syringe gets an average annual sales of 1.5 billion ~ China medical thermometer 1.6 billion cigarettes. The filling type syringe sales in the European and American countries YiXie the market is very mature, this will not be a breakthrough growth. And in the developing countries is still not high sales, in China, for example, although more than 90 million Chinese people with diabetes, but the annual sales insulin pen only 300000 ~ 500000 cigarettes a year. Once China, Brazil, South Africa, and newly industrialized insulin pen etc the filling syringes product market can open type,digital blood pressure monitor if in the future, this kind of product international market will have huge growth.
Medicinal aerosol inhaler
This product is one of YaoXie digital thermometer manufacturer product second best seller products. The global annual billions of pot, among them, medicinal aerosol about 35% ~ 40%, other aerosol including clean air aerosol and destroy insects spirit fogdigital thermometer , daily products. Medicinal aerosol average annual growth rate of only 4% ~ 6%.
More than 300 million people around the world suffer from asthma, and the treatment of asthma best means is the use of asthma inhaler aerosol inhalation drug, presently European and American manufacturers have listed dozens of different brand development only the cure asthma inhaler aerosol products.. According to data released by the F&S company, originally expected to reach 2015 in the global medicinal aerosol inhaler market sales amount to $13 billion, by 2011 have been $12 billion trade surplus trend, the $13 billion goal will be reached in advance. In the world's ten largest resistance to asthma drug, namely have seven for aerosol inhaler products; The international medical market last year on the top 200 drugs, six for aerosol inhaler products.
China firms also have developed YiErShiZhi Chinese medicine aerosol new products, but at present domestic aerosol inhaler products overseas brand occupied more than 90% share of the market. The western market analysts have said, aerosol inhaler development prospect is good, but unless domestic enterprise can develop better than foreign products of aerosol inhaler products, or difficult to change the present moment of weakness.
Take medicine implanted type equipment
The international market to take medicine implantable stents and insulin pump for this kind of product of two representative products. In 2010, the total sales stents has nearly $10 billion large expected this year, will break through the $10 billion mark. China's annual 300000 accept stent implants, domestic stent market growth is a huge space. If our country installation stents can price drops further, believe that each year millions of people in the future will be installed stents, installation stents can save severe atherosclerosis and coronary heart disease of lives, and is expected to make it become the most potential for growth YiXie of one of the products.
In contrast, insulin pump in our sales more not satisfied. The product in the domestic market price is in 40000 to 50000 yuan per only RMB, in the market have other oral medications can choose case, if the insulin pump price in the short period not decrease, then in the next few years this product sales market in our country also won't have substantial growth. In a foreign country, insulin pumps have been included in the scope of medical treatment insurance to submit an expense account, so the sales situation is better.